Nursing: Management of Drug Challenges: Generic vs. Branded Drugs
31.95
Online
Elective
Please select your state to enroll in this course
About the Course:
With health care and drug costs continuing to be high, there is continuing dialogue about the differences between brand name and generic drugs. This course is appropriate for all nurses and advanced practice nurses who have responsibility for managing or prescribing medications for select individuals.  The course addresses the history of brand versus generic drugs, the many controversies, the science behind the preparation differences, and the cost effectiveness of preventative care when using generic versus brand name drugs. 

Learning Outcomes:
Upon completion of this course, the learner should be able to:
  • List the properties that are identical in an FDA-approved brand and a generic drug. 
  • Identify two goals of a new drug application.
  • Identify why a generic drug could be “B” rated by the FDA.
  • Name the biologic drug term analogous to generic drug.
  • Quantify the portion of health care spending attributed to the cost of medications.
  • Identify two types of testing required for FDA approval of a biosimilar.
  • Realize the ratio of lobbying dollars spent by the generic drug industry relative to the brand name industry.
  • Compare the cost effectiveness of preventive care when using generic versus brand name drugs.

About the Author:
Diana M. Sobieraj, PharmD, FCCP, BCPS, earned her doctor of pharmacy degree from the University of Rhode Island and subsequently completed a pharmacy practice residency at Hartford Hospital/University of Connecticut School of Pharmacy. Dr. Sobieraj joined the faculty at UConn School of Pharmacy, where she has worked for the past 12 years, during which she completed her research training. Currently, Dr. Sobieraj is an assistant professor in the Department of Pharmacy Practice in the tenure track. Dr. Sobieraj’s scholarly interests focus on comparative effectiveness and health outcomes research, where she has more than 60 publications in the peer-reviewed literature, including journals such as JAMA, Annals of Internal Medicine, and the Journal of the American Geriatrics Society. Dr. Sobieraj has over $2.5 million in research grants and serves as a senior investigator and program manager for the AHRQ-funded UConn Evidence-Based Practice Center. Her most recent accomplishment is serving as the principal investigator for the AHRQ-funded evidence review commissioned by the National Heart, Lung, and Blood Institute for updating the EPR-3 guidelines for the management of asthma. She is a preceptor in the UConn Health Outcomes Fellowship program and for the PGY-1 Residency program at Hartford Hospital, where she serves as a research adviser and preceptor for an academic rotation. Dr. Sobieraj is a member of ACCP, the chair of the ACCP Health Outcomes PRN, and a member of the Community Advisory Panel of the ACCP Practice-Based Research Network.

How to receive credit:
  • Read the entire course online or in print which requires a 4-hour commitment of time.
  • Depending on your state requirements you will be asked to complete either:
    • An affirmation that you have completed the educational activity.
    • A mandatory test (a passing score of 70 percent is required). Test questions link content to learning objectives as a method to enhance individualized learning and material retention.
  • Provide required personal information and payment information.
  • Complete the mandatory Self-Assessment and Course Evaluation.
  • Print your Certificate of Completion.

Disclosures:

Resolution of Conflict of Interest
In accordance with the ANCC Standards for Commercial Support for continuing education, Colibri Healthcare, LLC implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity.

Sponsorship/Commercial Support and Non-Endorsement
It is the policy of Colibri Healthcare, LLC not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.

Disclaimer
The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
©2019: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Colibri Healthcare, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Colibri Healthcare, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Colibri Healthcare, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing, but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers.
 
Want Unlimited CE? Become a Member

Management of Drug Challenges: Generic vs. Branded Drugs - N28952

31.95
About the Course:
With health care and drug costs continuing to be high, there is continuing dialogue about the differences between brand name and generic drugs. This course is appropriate for all nurses and advanced practice nurses who have responsibility for managing or prescribing medications for select individuals.  The course addresses the history of brand versus generic drugs, the many controversies, the science behind the preparation differences, and the cost effectiveness of preventative care when using generic versus brand name drugs. 

Learning Outcomes:
Upon completion of this course, the learner should be able to:
  • List the properties that are identical in an FDA-approved brand and a generic drug. 
  • Identify two goals of a new drug application.
  • Identify why a generic drug could be “B” rated by the FDA.
  • Name the biologic drug term analogous to generic drug.
  • Quantify the portion of health care spending attributed to the cost of medications.
  • Identify two types of testing required for FDA approval of a biosimilar.
  • Realize the ratio of lobbying dollars spent by the generic drug industry relative to the brand name industry.
  • Compare the cost effectiveness of preventive care when using generic versus brand name drugs.

About the Author:
Diana M. Sobieraj, PharmD, FCCP, BCPS, earned her doctor of pharmacy degree from the University of Rhode Island and subsequently completed a pharmacy practice residency at Hartford Hospital/University of Connecticut School of Pharmacy. Dr. Sobieraj joined the faculty at UConn School of Pharmacy, where she has worked for the past 12 years, during which she completed her research training. Currently, Dr. Sobieraj is an assistant professor in the Department of Pharmacy Practice in the tenure track. Dr. Sobieraj’s scholarly interests focus on comparative effectiveness and health outcomes research, where she has more than 60 publications in the peer-reviewed literature, including journals such as JAMA, Annals of Internal Medicine, and the Journal of the American Geriatrics Society. Dr. Sobieraj has over $2.5 million in research grants and serves as a senior investigator and program manager for the AHRQ-funded UConn Evidence-Based Practice Center. Her most recent accomplishment is serving as the principal investigator for the AHRQ-funded evidence review commissioned by the National Heart, Lung, and Blood Institute for updating the EPR-3 guidelines for the management of asthma. She is a preceptor in the UConn Health Outcomes Fellowship program and for the PGY-1 Residency program at Hartford Hospital, where she serves as a research adviser and preceptor for an academic rotation. Dr. Sobieraj is a member of ACCP, the chair of the ACCP Health Outcomes PRN, and a member of the Community Advisory Panel of the ACCP Practice-Based Research Network.

How to receive credit:
  • Read the entire course online or in print which requires a 4-hour commitment of time.
  • Depending on your state requirements you will be asked to complete either:
    • An affirmation that you have completed the educational activity.
    • A mandatory test (a passing score of 70 percent is required). Test questions link content to learning objectives as a method to enhance individualized learning and material retention.
  • Provide required personal information and payment information.
  • Complete the mandatory Self-Assessment and Course Evaluation.
  • Print your Certificate of Completion.

Disclosures:

Resolution of Conflict of Interest
In accordance with the ANCC Standards for Commercial Support for continuing education, Colibri Healthcare, LLC implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity.

Sponsorship/Commercial Support and Non-Endorsement
It is the policy of Colibri Healthcare, LLC not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.

Disclaimer
The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
©2019: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Colibri Healthcare, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Colibri Healthcare, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Colibri Healthcare, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing, but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers.